Web Event: Rx Drugs and the U.S. Health System – A Conversation About Drug Prices July 7, 2016 Event The Kaiser Family Foundation will host a web conversation to discuss the drivers of recent and forecasted trends in prescription drug spending and examine how drug prices are set.
Visualizing Health Policy: A Snapshot of Cancer Spending and Outcomes June 21, 2016 News Release This Visualizing Health Policy infographic provides details on cancer spending and outcomes in the United States.
What Are the Current Costs and Outcomes Related to Mental Health and Substance Abuse Disorders? May 6, 2016 Slideshow
Most Americans Say Federal and State Governments Are Not Doing Enough to Combat Prescription Painkiller and Heroin Abuse; Large Majorities Believe Wide Range of Strategies Would be Effective May 3, 2016 News Release As the White House and Congress continue to debate new funding and other actions to address the nation’s opioid epidemic, the latest Kaiser Health Tracking Poll finds that most Americans believe the federal government is not doing enough to combat the recent increases in the number of people who are…
Kaiser Family Foundation Survey of Pennsylvania Residents April 13, 2016 Poll Finding The Kaiser Family Foundation Survey of Pennsylvania Residents measures Pennsylvanians’ opinions about a selection of health issues, including which issues they believe state policymakers should prioritize, opinions about prescription painkiller abuse, and experiences accessing and paying for health care. The survey was conducted March 7-15, 2016 among a representative sample of 804 adults ages 18 and over living in Pennsylvania.
Visualizing Health Policy: Recent Trends in Prescription Drug Costs April 5, 2016 Infographic This Visualizing Health Policy infographic with JAMA spotlights national spending on prescription drugs and the public’s views on pharmaceutical prices.
Visualizing Health Policy: Recent Trends in Prescription Drug Costs April 5, 2016 News Release This Visualizing Health Policy infographic spotlights national spending on prescription drugs and the public’s views on pharmaceutical prices. Prescription drug spending rose sharply in 2014, driven by growth in expenditures on specialty drugs, including medications to treat cancer and hepatitis C. Medicare’s spending on prescription pharmaceuticals also has risen, largely…
A New Way of Measuring Health Costs Sheds Light on Recent Health Spending Trends March 29, 2016 Issue Brief National health spending started to grow more rapidly recently after several years of unusually slow growth. This analysis from the Kaiser Family Foundation and the federal Bureau of Economic Analysis helps to dissect why that may be happening. Using recently-released disease-based health spending data compiled by the federal government, the analysis finds…
Allowing Medicare to Negotiate Drug Prices Is A Popular Idea But May Not Produce Substantial Savings February 9, 2016 News Release In response to rising drug costs, some policymakers and presidential candidates, including Republican Donald Trump and Democrats Hillary Clinton and Bernie Sanders, have proposed allowing Medicare to negotiate directly with pharmaceutical companies over the price of prescription drugs, in contrast to the current approach under Medicare Part D drug where…